Abstract:PurposeThis paper reflects on the evolution of China's drug distribution industry from the planned economy era to the most recent dramatic shift, with a major focus on the analysis of the government's efforts of centralizing the drug distribution channel through adoption of e‐bidding platforms. In a broader sense, the Chinese government's effort is a showcase of the so‐called “Chinese model” of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. The purpose of this paper is to analyse the limitations and problems of this mode of implementing institutional change.Design/methodology/approachThe analytical framework draws upon Williamson's theory of the mechanism of governance and insights from new institutional economics on institutional changes. The information used in this study is based on the authors' more than 40 interviews with a variety of pharmaceutical industry stakeholders, including government agencies, hospitals, pharmaceutical manufacturers, distributors, and electronic bidding platforms providers.FindingsThe failure of implementing third party electronic platforms based drug procurement practices shows the importance of aligning the mode of governing transactions with the macro level institutional environment and the micro level individual behavioral traits, and the government's decision of taking over the ownership of transaction platforms has further corroborated this logic.Originality/valueThis paper is an effort to analyze the logic behind the Chinese model of implementing institutional change: the government initiates a project and counts on its fiat to gain compliance and support from the involved stakeholders. From the academic perspective, this paper contributes to literature on the analysis of the interaction of technology adoption and institutional change.

Pharmaceutical E-Business In China: A Case Of A Pharmaceutical E-Commerce Company

Analysis of e-commerce application in pharmaceutical enterprises—A case study of Yaofang.cn

Transforming Inter-Organizational Information Systems into Electronic Commerce Marketplaces: Development of B2B Electronic Commerce in China’s Pharmaceutical Industry

A brief analysis of favorable and unfavorable conditions for future development of pharmaceutical E-commerce in China

A Value Chain Based Analysis of Electronic Commerce's Transformation of China 's Pharmaceutical Industry

Development of B to C E-commerce in Pharmaceutical Industry and the Strategy for the Development of E-commerce in China's Pharmaceutical Retail Chains

Enhancing the Efficacy of Pharmaceutical E-Commerce Through Omni-Channel Coordination

Feasibility Study on the Chain Pharmacies into Medical E-commerce Field

Legal aspects of pharmaceutical E-commerce development against the " Internet+ " scenario

[E-commerce of pharmaceuticals]

Research on Consumer Satisfaction in Pharmaceutical E-commerce based on Review Texts

Design of the Internet plus Drug Circulation Business Model Based on Value Chain

Electronic commerce in China: emerging success stories

Government Driven Model of Institutional Change Through Adoption of New Technology A Case Study of the Failed Pharmaceutical Bidding and Procurement Platforms in China

Network Relations and Boundary Spanning: Understanding the Evolution of E-Ordering in the Chinese Drug Distribution Industry

New driving force for China's import growth: Assessing the role of cross-border e-commerce

E‐commerce development in China and its implication for business

The Current Status and Development Countermeasures of Online Pharmacies in China

Interaction of Technological and Institutional Change in the Development of an Electronic Commerce System in China'S Pharmaceutical Distribution Chain - A Transaction Cost Perspective

E-Business in Enterprise Marketing Strategy Analysis

The Development of the Foreign Online Pharmacies in Field of Regulation and Operational System